- CA$2.74m
- CA$2.65m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.57 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -87.63% | ||
| Return on Equity | -94.93% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Aug | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | 1.5 | 1.5 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Algernon Health Inc., formerly Algernon Pharmaceuticals Inc., is a Canadian healthcare company. The Company is focused on the provision of brain-specific PET scanning services through a planned network of new clinics in North America for the early-stage detection of Alzheimer’s disease, as well as other forms of dementia, epilepsy, neuro-oncology, and movement disorders. It is also the parent company of a private subsidiary called Algernon NeuroScience that has been advancing a psychedelic program investigating a proprietary form of DMT for stroke and traumatic brain injury recovery. The Company also owns a 20% equity position in Seyltx, a private U.S-based drug development company advancing a chronic cough drug called Ifenprodil.
Directors
- Last Annual
- August 31st, 2024
- Last Interim
- May 31st, 2025
- Incorporated
- April 10th, 2015
- Public Since
- February 1st, 2016
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Canadian Securities Exchange- Shares in Issue
- 34,256,219
- Address
- Suite 400 - 601 West Broadway, VANCOUVER, V5Z 4C2
- Web
- https://algernonpharmaceuticals.com
- Phone
- +1 6043984175
- Auditors
- Smythe LLP
Upcoming Events for AGN
Q1 2026 Algernon Pharmaceuticals Inc Earnings Release
Similar to AGN
Albert Labs International
Canadian Securities Exchange
Asep Medical Holdings
Canadian Securities Exchange
BetterLife Pharma
Canadian Securities Exchange
BioMark Diagnostics
Canadian Securities Exchange
Biovaxys Technology
Canadian Securities Exchange
FAQ
What is the Algernon Health share price?
As of Today at 19:10 UTC, shares in Algernon Health are trading at CA$0.08. This share price information is delayed by 15 minutes.
How has the Algernon Health share price performed this year?
Shares in Algernon Health last closed at CA$0.08 and the price had moved by -5.88% over the past 365 days. In terms of relative price strength the Algernon Health share price has underperformed the Toronto Stock Exchange 300 Composite Index by -22.41% over the past year.
What are the analyst and broker recommendations for Algernon Health?
The overall consensus recommendation for Algernon Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Algernon Health dividend yield?
Algernon Health does not currently pay a dividend.
Does Algernon Health pay a dividend?
Algernon Health does not currently pay a dividend.
When does Algernon Health next pay dividends?
Algernon Health does not currently pay a dividend.
How do I buy Algernon Health shares?
To buy shares in Algernon Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Algernon Health?
As of the previous close price of CA$0.08, shares in Algernon Health had a market capitalisation of CA$2.74m.
Where are Algernon Health shares listed?
Here are the trading details for Algernon Health:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: AGN
What kind of share is Algernon Health?
Based on an overall assessment of its quality, value and momentum Algernon Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Algernon Health share price forecast for 2025?
The analyst consensus target price for shares in Algernon Health is CA$2.56. That is 3100% above the last closing price of CA$0.08.
Analysts covering Algernon Health currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.54 for the next financial year.
Find out moreWhat is the trend in the Algernon Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Algernon Health. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -24.95%.
As of the last closing price of CA$0.08, shares in Algernon Health were trading +1.67% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Algernon Health PE Ratio?
The Algernon Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Algernon Health?
We do not have data on Algernon Health's directors